Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Sales | 11,252 | 12,854 | 7,204 | 6,550 | 6,445 |
Gross Profit | 11,252 | 12,854 | 7,204 | 6,550 | 6,445 |
Operating Expenses | 155,498 | 93,269 | 79,197 | 75,567 | 52,870 |
Operating Income | -144,246 | -80,415 | -71,993 | -69,017 | -46,425 |
Other Income | -2,626 | -822 | 349 | 211 | 220 |
Pre-tax Income | -146,872 | -81,237 | -71,644 | -68,806 | -46,205 |
Net Income Continuous | -146,872 | -81,237 | -71,644 | -68,806 | -46,205 |
Net Income | $-146,872 | $-81,237 | $-71,644 | $-68,806 | $-46,205 |
EPS Basic Total Ops | -1.96 | -1.11 | -0.97 | -1.01 | -0.69 |
EPS Basic Continuous Ops | -1.96 | -1.11 | -0.97 | -1.01 | -0.69 |
EPS Diluted Total Ops | -1.96 | -1.11 | -0.97 | -1.01 | -0.69 |
EPS Diluted Continuous Ops | -1.96 | -1.11 | -0.97 | -1.01 | -0.69 |
EBITDA(a) | $-142,492 | $-78,535 | $-70,207 | $-67,383 | $-44,834 |